NCT00658658View on ClinicalTrials.gov

Panitumumab in Children With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Solid Tumors
Interventions
BIOLOGICAL

Panitumumab

Panitumumab administered by intravenous infusion

Trial Locations (11)

10021

Research Site, New York

20010

Research Site, Washington D.C.

37232

Research Site, Nashville

44106

Research Site, Cleveland

55455

Research Site, Minneapolis

60611

Research Site, Chicago

64108

Research Site, Kansas City

77030

Research Site, Houston

90027

Research Site, Los Angeles

94143

Research Site, San Francisco

97239-3098

Research Site, Portland

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00658658 - Panitumumab in Children With Solid Tumors | Biotech Hunter | Biotech Hunter